February 9, 2026 Experience AgomAb Therapeutics $200 million IPO We advised the representatives of the several underwriters on the IPO
February 9, 2026 Experience Meituan $717 million acquisition of Dingdong’s China business We are advising Meituan on the transaction
February 9, 2026 Experience ANE privatization and delisting We advised ANE on its privatization and delisting by way of a scheme of arrangement
February 6, 2026 Experience Eikon Therapeutics $381 million IPO We advised the representatives of the several underwriters on the IPO
February 6, 2026 Experience Genius Sports $1.07 billion Legend acquisition financing We are advising the lead arrangers and lenders on the financing
February 6, 2026 Experience GE Vernova $2.6 billion debut senior notes offering We advised the representatives of the underwriters on the offering
February 6, 2026 Experience Kosmos Energy $250 million tender offer We advised Kosmos on the tender offer
February 6, 2026 Experience Maze Therapeutics $200 million at-the-market offering We advised the sales agent on the offering
February 6, 2026 Experience First Citizens BancShares $400 million preferred stock offering We advised the representatives of the underwriters on the offering
February 5, 2026 Experience Uniti Group $1 billion senior notes tack-on offering We advised Uniti on its high-yield notes offering